Whittier Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Whittier Trust's ALNY Position: Q3 2026 in Review
Whittier Trust held its Alnylam Pharmaceuticals (ALNY) position steady in Q3 2026 at 94 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.
Whittier Trust first reported a position in ALNY in Q3 2019 and has held it in 29 quarters since. The position peaked at $31.5K in Q3 2025. 720 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Whittier Trust held 94 shares of Alnylam Pharmaceuticals worth $21.9K as of Q3 2026.
- Whittier Trust left its Alnylam Pharmaceuticals share count unchanged in Q3 2026.
- Alnylam Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q3 2026, its #1011 holding.
- Whittier Trust first reported a position in Alnylam Pharmaceuticals in Q3 2019 and has held it in 29 quarters since.
- Whittier Trust's Alnylam Pharmaceuticals position peaked at $31.5K in Q3 2025.
- 720 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Whittier Trust's 13F filing for Q3 2026, filed 12 Nov 2026.